Nithya Balasubramanian

IKS Health reported Q1 FY27 revenue of INR 8,936 million, a 20.7% year‑over‑year increase. EBITDA rose to INR 2,949 million, representing 33% of revenue and a 24% YoY growth. PAT increased 27.8% YoY t